Friday, December 16, 2016

BRIEF-Xbiotech says received Day 180 List Of Outstanding Issues from EMA for Xilonix - SEC filing

* Xbiotech-Announced it received Day 180 List Of Outstanding

Issues from European Medicines Agency's Committee for Medicinal

Products for Human Use

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)